Cardiac Marker Testing Devices Market, By
Marker Type, Product Type, Application,
Testing Type, and End User - Global Industry
Insights, Trends, Outlook and Opportunity
Analysis, 2018-2026
Cardiac markers are diagnostic tool, which are associated for diagnosis and risk detection in
patients suffering from chest pain, acute coronary syndrome (ACS), and acute myocardial infraction
(MI). Cardiac marker test detects the endogenous substances, which are released during the blood
circulation mainly when the heart is damaged or stressed, thereby, assessing risk and directing
appropriate therapy that improves clinical outcome in high-risk patients. Cardiac markers are used
in hospitals to either detect cardiac injury or to evaluate future risk of cardiovascular disease.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/1039
Myoglobin, homocysteine, troponin T (cTnT), troponin I (cTnl), creatine kinase-MB (CK-MB), and
C-reactive protein (CRP) are cardiac markers used for assessment of acute myocardial infraction.
However, CK-MB, cTnl, and cTnT are used to identify and manage acute coronary syndrome in
high-risk patients. Cardiac troponin I and T are most preferred and extensively used cardiac marker